Special Winter 2026Preview: Gene editingIn its Winter 2026 issue, European Biotechnology will spotlight the companies, technologies and partnerships shaping Europe’s gene editing sector, from emerging platforms and therapeutic applications … more ➔
Special Winter 2026Preview: RadiopharmaceuticalsIn its Winter 2026 issue, European Biotechnology will spotlight the companies, technologies and partnerships shaping Europe’s radiopharmaceutical sector, from emerging therapeutic targets to the … more ➔
Special Autumn 2026Special: CROs & CDMOsCDMOs and CROs need to integrate new clinical trial designs, innovative drug modalities, and AI into their service portfolios. At the same time, they are facing a shortage of qualified personnel. more ➔
Special Autumn 2026Special: Autoimmune & inflammatory diseasesTreatment options for autoimmune and inflammatory diseases are evolving from blanket immunosuppression towards more targeted approaches. more ➔
Special Autumn 2026Preview: Focus on Spain at BIOSPAIN 2026Invitation to participate in the multi-page Spain special in the European Biotechnology Magazine on the occasion of BIOSPAIN 2026 in Bilbao. more ➔
Special Summer 2026Special: RNA TechnologiesThe COVID-19 pandemic demonstrated the efficacy of mRNA vaccine delivery, and other applications, particularly in oncology, are now being explored. more ➔
Special Summer 2026Special: Drug Delivery ServicesFor years, drug delivery sat downstream of discovery but that hierarchy is changing. In a market shaped by biologics, chronic disease, payer pressure and overloaded health systems, how a medicine reaches … more ➔
Special Spring 2026Special: Lab automation + data scienceLaboratory automation is evolving fast. What used to be a patchwork of isolated device solutions has steadily moved toward smarter, interconnected labs. And now that robotics is pushing the field one … more ➔
Special Spring 2026Special: CDMO Landscape EuropeToday, 90% of biotechs outsource manufacturing to CDMOs. Outsourcing decisions are no longer straightforward cost-benefit analyses. Geopolitical volatility and unprecedented demand for advanced modalities … more ➔
Special Winter 2025Euro BioFairs CompassGuide to European Life Sciences Events in the first half year of 2026 more ➔
